Cabaletta Bio Inc.

CABA | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.46

-$0.09 (-3.53%)

At close: Sep 21, 2026, 4:00 PM ET

$2.46

$0 (0.00%)

Pre-market: Sep 22, 2026, 6:25 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.53%

(1D)

Rating

Updated: Aug 28, 2026

16.5

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $401.11M

1D Range

2.45 2.65

52W Range

2 4.23

Valuation (TTM)

PE -1.56

PB 1.90

EV/EBITDA -1.14

Valuation (NTM)

Forward PE N/A

Forward PEG 0.13

Price Target $16.33

Cash Flow

FCF Yield -38.5%

SBC Adj. FCF Yield -43.6%

SBC Impact -13.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 8.0% | -2.8%

FCF 3Y | 5Y -35.0% | -32.2%

Returns

ROA -70.6%

ROE -128.3%

ROIC -78.5%

Financial Health

Net Cash

$225.1M

Current Ratio 5.79

Interest Coverage -80.94

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T cell therapies. Its core mission is to treat ...

Sector Healthcare

Industry Biotechnology

Employees 156

IPO Date Oct 24, 2019

Website www.cabalettabio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$14

Upside

+469.11%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞